In addition to the direct effects of TGF-β1 signaling on HNSCC cells, TGF-β1 together with interleukin-17 (IL-17A) primes tumor-associated neutrophils to adopt a tumor-promoting phenotype and induce EMT-related functional changes in OSCC [72]. The gene discussed is TGFB1; the disease is neoplasm.